ARCHIVES

HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing

This article is from The Cancer Letter archive.

Vol. 19 No. 45 | November 19, 1993

Download PDF Visit The Full Archive

Related Articles

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

AACR President Coffey Urges Clinton to Support Doubling of NIH, NCI Budgets

December 19, 1997

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

October 30, 2009

In Brief: Howley, Simone Lead Cancer Policy Board: AMA Campaign Fights Youth Smoking

November 22, 1996